Registro:

Referencias:

• Albini, A., Tosetti, F., Benelli, R., Noonan, D.M., Tumor inflammatory angiogenesis and its chemoprevention (2005) Cancer Res., 65, pp. 10637-10641
• Alché, L.E., Assad Ferek, G., Meo, M., Coto, C., Maier, M., An antiviral meliacarpin from leaves of Melia azedarach L (2003) Z. Naturforsch. C, 58, pp. 215-219
• Barquero, A.A., Alché, L.E., Coto, C., Block of vesicular stomatitis virus endocytic and exocytic pathways by 1-cinnamoyl-3,11-dihydroxymeliacarpin, a tetranortriterpenoid of natural origin (2004) J. Gen. Virol., 85, pp. 483-493
• Barquero, A.A., Michelini, F.M., Alché, L.E., 1-Cinnamoyl-3,11-dihydroxymeliacarpin is a natural bioactive compound with antiviral and nuclear factor-kappaB modulating properties (2006) Biochem. Biophys. Res. Commun., 344, pp. 955-962
• Biswas, P.S., Rouse, B.T., Early events in HSV keratitis - setting the stage for a blinding disease (2005) Microbes Infect., 7, pp. 799-810
• Biswas, P.S., Banerjee, K., Kinchington, P.R., Rouse, B.T., Involvement of IL-6 in the paracrine production of VEGF in ocular HSV-1 infection (2006) Exp. Eye Res., 82, pp. 46-54
• Bueno, C.A., Barquero, A.A., Di Cónsoli, H., Maier, M.S., Alché, L.E., A natural tetranortriterpenoid with immunomodulating properties as a potential anti-HSV agent (2009) Virus Res., 141, pp. 47-54
• Bueno, C.A., Alché, L.E., Barquero, A.A., 1-Cinnamoyl-3,11-dihydroxymeliacarpin delays glycoprotein transport restraining virus multiplication without cytotoxicity (2010) Biochem. Biophys. Res. Commun., 393, pp. 32-37
• Carrasco, M.A., Subconjunctival bevacizumab for corneal neovascularization in herpetic stromal keratitis (2008) Cornea, 27, pp. 743-745
• Cook, K.M., Figg, W.D., Angiogenesis inhibitors: current strategies and future prospects (2010) CA Cancer J. Clin., 60, pp. 222-243
• Davel, L.E., Rimmaudo, L., Español, A., De La Torre, E., Jasnis, M.A., Ribeiro, M.L., Gotoh, T., Sales, M.E., Different mechanisms lead to the angiogenic process induced by three adenocarcinoma cell lines (2004) Angiogenesis, 7, pp. 45-51
• De Luisi, A., Mangialardi, G., Ria, R., Acuto, G., Ribatti, D., Vacca, A., Anti-angiogenic activity of carebastine: a plausible mechanism affecting airway remodelling (2009) Eur. Respir. J., 34, pp. 958-966
• Denizot, F., Lang, R., Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability (1986) J. Immunol. Methods, 89, pp. 271-277
• Duan, R., de Vries, R.D., Osterhaus, A.D., Remeijer, L., Verjans, G.M., Acyclovir-resistant corneal HSV-1 isolates from patients with herpetic keratitis (2008) J. Infect. Dis., 198, pp. 659-663
• Ebrahem, Q., Minamoto, A., Hoppe, G., Anand-Apte, B., Sears, J., Triamcinolone acetonide inhibits IL-6 and VEGF-induced angiogenesis downstream of the IL-6 and VEGF receptors (2006) Invest. Ophthalmol. Vis. Sci., 47, pp. 4935-4941
• Fujita, S., Saika, S., Kao, W., Fujita, K., Miyamoto, T., Ikeda, K., Nakajima, Y., Ohnishi, Y., Endogenous TNFalpha suppression of neovascularization in corneal stroma in mice (2007) Invest. Ophthalmol. Vis. Sci., 48, pp. 3051-3055
• Hashizume, M., Hayakawa, N., Suzuki, M., Mihara, M., IL-6/sIL-6R trans-signalling, but not TNF-alpha induced angiogenesis in a HUVEC and synovial cell co-culture system (2009) Rheumatol. Int., 29, pp. 1449-1454
• He, M.F., Liu, L., Ge, W., Shaw, P.C., Jiang, R., Wu, L.W., But, P.P., Antiangiogenic activity of Tripterygium wilfordii and its terpenoids (2009) J. Ethnopharmacol., 121, pp. 61-68
• Knickelbein, J.E., Hendricks, R.L., Charukamnoetkanok, P., Management of herpes simplex virus stromal keratitis: an evidence-based review (2009) Surv. Ophthalmol., 54, pp. 226-234
• Lin, C.M., Chang, H., Chen, Y.H., Li, S.Y., Wu, I.H., Chiu, J.H., Protective role of wogonin against lipopolysaccharide-induced angiogenesis via VEGFR-2, not VEGFR-1 (2006) Int. Immunopharmacol., 6, pp. 1690-1698
• Pifarré, M.P., Berra, A., Coto, C.E., Alché, L.E., Therapeutic action of meliacine, a plant-derived antiviral, on HSV-induced ocular disease in mice (2002) Exp. Eye Res., 75, pp. 327-334
• Radtke, S., Wüller, S., Yang, X., Lippok, B.E., Mütze, B., Mais, C., de Leur, H.S., Hermanns, H.M., Cross-regulation of cytokine signaling: pro-inflammatory cytokines restrict IL-6 signaling through receptor internalization and degradation (2010) J. Cell Sci., 123, pp. 947-959
• Urtreger, A., Ladeda, V., Puricelli, L., Rivelli, A., Vidal, M., Delustig, E., Joffe, E., Modulation of fibronectin expression and proteolytic activity associated with the invasive and metastatic phenotype in two new murine mammary tumor cell lines (1997) Int. J. Oncol., 11, pp. 489-496
• Yeung, S.N., Lichtinger, A., Kim, P., Amiran, M.D., Slomovic, A.R., Combined use of subconjunctival and intracorneal bevacizumab injection for corneal neovascularization (2011) Cornea, 30, pp. 1110-1114
• Zheng, M., Schwarz, M.A., Lee, S., Kumaraguru, U., Rouse, B.T., Control of stromal keratitis by inhibition of neovascularization (2001) Am. J. Pathol., 159, pp. 1021-1029
• Zheng, M.E., Deshpande, S., Lee, S., Ferrara, N., Rouse, B.T., Contribution of vascular endothelial growth factor in the neovascularization process during the pathogenesis of herpetic stromal keratitis (2001) J. Virol., 75, pp. 9828-9835

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------